Cefdinir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-327 -
Package NDC
76420-327-01 -
Package NDC
76420-327-60 -
Application number
ANDA065259 -
SPL ID
331b63bf-fd36-155d-e063-6294a90aec23 -
SPL set ID
e90660c8-2714-4592-aeaa-bc9ceb26057c -
UNII
CI0FAO63WC -
RxCUI
309054 -
RxCUI
476576
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Cefdinir
- Form
- POWDER, FOR SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cefdinir",
"splId": "331b63bf-fd36-155d-e063-6294a90aec23",
"labels": [
{
"setId": "e90660c8-2714-4592-aeaa-bc9ceb26057c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e90660c8-2714-4592-aeaa-bc9ceb26057c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e90660c8-2714-4592-aeaa-bc9ceb26057c"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 mL in 1 BOTTLE (76420-327-01)",
"package_ndc": "76420-327-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20250419"
},
{
"sample": false,
"description": "60 mL in 1 BOTTLE (76420-327-60)",
"package_ndc": "76420-327-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20250419"
}
],
"productId": "76420-327_331b63bf-fd36-155d-e063-6294a90aec23",
"useDomain": "unknown",
"dosageForm": "POWDER, FOR SUSPENSION",
"productNdc": "76420-327",
"deaSchedule": null,
"genericName": "Cefdinir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CEFDINIR",
"strength": "125 mg/5mL"
}
],
"applicationNumber": "ANDA065259",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20060531",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175488",
"M0003827"
],
"unii": [
"CI0FAO63WC"
],
"rxcui": [
"309054",
"476576"
],
"spl_set_id": [
"e90660c8-2714-4592-aeaa-bc9ceb26057c"
],
"pharm_class_cs": [
"Cephalosporins [CS]"
],
"pharm_class_epc": [
"Cephalosporin Antibacterial [EPC]"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-327_331b63bf-fd36-155d-e063-6294a90aec23"